The Diagnostic Value of Immunohistochemistry Markers in Hirschsprung Disease; A Systematic Review and Meta-analysis

Harry L Claxton,Shehrazed A Lounis,Michael Stanton,Nigel J Hall,Bashar Aldeiri
DOI: https://doi.org/10.1016/j.jpedsurg.2024.162010
2024-10-17
Abstract:Background: Immunohistochemistry (IHC) markers are employed to improve the diagnostic yield when testing for Hirschsprung disease (HSCR). Yet, a superior test has not been identified. Objectives: We aimed to determine the diagnostic test accuracy (DTA) of IHC markers. Methods: We conducted database search for studies reporting IHC staining on rectal biopsy investigating for HSCR. We constructed 2 × 2 contingency tables, and calculated DTA estimates in pooled and paired testing using random-effect model meta-analysis. Results: Twenty eight IHC markers from 107 studies were used to investigate for HSCR in 10891 children. In pooled analysis; calretinin sensitivity and specificity were superior to acetylcholinesterase, S100, and peripherin [98 % (CI; 0.95-0.99) & 99 % (CI; 0.97-0.99)], [94 % (CI; 0.86-0.97) & 99 % (CI; 0.96-0.99)], [92 % (CI; 0.85-0.96) & 97 % (CI; 0.89-0.99)] and [91.7 % (CI; 0.54-0.98) & 94.8 % (CI; 0.59-0.99)], respectively. In paired analysis calretinin diagnostic odds ratio was superior to hematoxylin and eosin (H&E), acetylcholinesterase and S100: [3349 (PI; 551.3-22667.2) vs 345.3 (PI; 54.9-2394.2)], [300.9 (PI; 13.3-4146.9) vs 34.6 (PI; 2.2-363.9)] and [696.9 (PI; 91.2-3401.7) vs 196.9 (PI; 29.8-890.5)], respectively. In biopsies labelled inadequate for H&E testing, calretinin specificity to rule out HSCR reached 92 % (CI; 0.288-0.998). Conclusions: IHC provides additional diagnostic value over H&E. Calretinin appears to be, currently, a superior IHC marker. The available literature is of variable quality, cautious interpretation of the findings should be considered. Level of evidence: III.
What problem does this paper attempt to address?